Benefits of pulsatile flow during and after cardiopulmonary bypass procedures

Artificial Organs

Volumn 29, Issue 9, 2005, Pages 688-690

  Ündar, Akif ^a  

^a PENN STATE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPULMONARY BYPASS;

ADRENALIN; CATECHOLAMINE; CYTOKINE; ENDOTHELIN 1; INTERLEUKIN 8; LACTIC ACID; NORADRENALIN;

CARDIOPULMONARY BYPASS; CLINICAL RESEARCH; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DEMOGRAPHY; EDITORIAL; ELECTROCARDIOGRAM; HUMAN; INTERMETHOD COMPARISON; KIDNEY FUNCTION; LUNG FUNCTION; NONHUMAN; PATIENT SELECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSATILE FLOW;

EID: 26444568149     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2005.02005.x     Document Type: Editorial

References (28)

1. Sezai A, Shiono M, Nakata K, et al. Effects of pulsatile CPB on interleukin-8 and endothelin-1 levels. Artif Organs 2005; 29:708-13.
2. Ündar A, Rosenberg G, Myers JL. Major factors in the controversy of pulsatile versus nonpulsatile flow during acute and chronic cardiac support [Editorial]. ASAIO J 2005;51:173-5.
3. Ündar A. Myths and truths of pulsatile and non-pulsatile perfusion during acute and chronic cardiac support [Editorial]. Artif Organs 2004;28:439-43.
4. Gu YJ, Dekroon TL, Elstrodt JM, Van Oeveren W, Boonstra PW, Rakhorst G. Augmentation of abdominal organ perfusion during cardiopulmonary bypass with a novel intra-aortic pulsatile catheter pump. Int J Artif Organs 2005;28:35-43.
5. Kim HK, Son HS, Fang YH, Park SY, Hwang CM, Sun K. The effects of pulsatile flow upon renal tissue perfusion during cardiopulmonary bypass: a comparative study of pulsatile and nonpulsatile flow. ASAIO J 2005;51:30-6.
6. Nakamura K, Harasaki H, Fukumura F, Fukamachi K, Whalen RL. Comparison of pulsatile and non-pulsatile cardiopulmonary bypass on regional renal blood flow in sheep. Scand Cardiovasc J 2004;38:1-5.
7. Herreros J, Berjano EJ, Sola J, et al. Injury in organs after cardiopulmonary bypass: a comparative experimental morphological study between a centrifugal and a new pulsatile pump. Artif Organs 2004;28:738-42.
8. Ündar A. Principles and practices of pulsatile perfusion in pediatric and adult open-heart surgery. Turk J Thorac Cardiovasc Surg 2004;12:215-9.
9. Ündar A. The ABCs of research on pulsatile versus nonpulsatile perfusion during cardiopulmonary bypass [Editorial]. Med Sci Monit 2002;8:ED21-4.
10. Orime Y, Shiono M, Hata H, et al. Cytokine and endothelial damage in pulsatile and non-pulsatile cardiopulmonary bypass. Artif Organs 1999;23:508-12.
11. Sezai A. Major organ microcirculation during assisted circulation-comparison studies of pulsatile and non-pulsatile assists. Ann Thorac Cardiovasc Surg 1996;2:215-23.
12. Ündar A, Lodge AJ, Daggett CW, Runge TM, Ungerleider RM, Calhoon JH. The type of aortic cannula and membrane oxygenator affect the pulsatile waveform morphology produced by a neonate-infant cardiopulmonary bypass system in vivo. Artif Organs 1998;22:681-6.
13. Gourlay T, Gibbons M, Taylor KM. Pulsatile flow compatibility of a group of membrane oxygenators. Perfusion 1987;2: 115-26.
14. Ündar A, Eichstaedt HC, Masai T, et al. Comparison of six pediatric cardiopulmonary bypass pumps during pulsatile and nonpulsatile perfusion. J Thoracic Cardiovasc Surg 2001;122: 827-9.
15. Ündar A, Koenig KM, Frazier OH, Fraser CD. Impact of membrane oxygenators on pulsatile versus nonpulsatile perfusion in a neonatal model. Perfusion 2000;15:111-20.
16. Shepard RB, Simpson DC, Sharp JF. Energy equivalent pressure. Arch Surg 1966;93:730-40.
17. Ündar A, Masai T, Frazier OH, Fraser CD Jr. Pulsatile and nonpulsatile flows can be quantified in terms of energy equivalent pressure during cardiopulmonary bypass for direct comparisons. ASAIO J 1999;45:610-4.
18. Ündar A, Frazier OH, Fraser CD Jr. Defining pulsatile perfusion: quantification in terms of energy equivalent pressure. Artif Organs 1999;23:712-6.
19. Ündar A, Eichstaedt HC, Clubb FJ Jr, et al. Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass. Ann Thorac Surg 2002;74:355-62.
20. Fung M, Loubser PG, Ündar A, et al. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits. J Thorac Cardiovasc Surg, 2001;122:113-22.
21. Murkin JM, Martzke JS, Buchan AM, Bentley C, Wong CJ. A randomized study of the influence of perfusion technique and pH management strategy in 316 patients undergoing coronary artery bypass surgery. I. Mortality and cardiovascular morbidity. J Thorac Cardiovasc Surg 1995;110:340-8.
22. Watarida S, Mori A, Onoe M, et al. A clinical study on the effects of pulsatile cardiopulmonary bypass on the blood endotoxin levels. J Thorac Cardiovasc Surg 1994;108:620-5.
23. Herreros J, Berjano EJ, Mas P, et al. Platelet dysfunction in cardiopulmonary bypass: an experimental comparative study between a centrifugal and a new pulsatile pump. Int J Artif Organs 2003;26:1086-94.
24. Ündar A, Lodge AJ, Daggett CW, Runge TM, Ungerleider RM, Calhoon JH. Design and performance of a physiologic pulsatile flow neonate-infant cardiopulmonary bypass system. ASAIO J 1996;42:M580-3.
25. Ündar A, Masai T, Beyer EA, et al. Pediatric physiologic pulsatile pump enhances cerebral and renal blood flow during and after cardiopulmonary bypass. Artif Organs 2002;26:919-23.
26. Ündar A, Masai T, Yang SQ, et al. Pulsatile perfusion improves regional myocardial blood flow during and after hypothermic cardiopulmonary bypass in a neonatal piglet model. ASAIO J 2002;48:90-5.
27. Ündar A, Masai T, Yang SQ, et al. Effects of perfusion mode on regional and global organ blood flow in a neonatal piglet model. Ann Thorac Surg 1999;68:1336-43.
28. Ündar A. Design and performance of physiologic pulsatile flow cardiopulmonary bypass systems for neonates and infants. PhD Dissertation. The University of Texas at Austin. May 1996.